Answers are grounded in this paper and cite their sources.
We applied targeted metabolic inhibitors to 145 Lachancea thermotolerans strains to uncover fermentation traits with direct relevance to wine quality. Oxamate, a lactate dehydrogenase inhibitor, reduced lactic acid and total titratable acidity by 21% and 26%, respectively, while increasing succinic acid and pH without affecting ethanol levels, offering a promising strategy to fine-tune wine freshness and balance. Notably, industrial grape-associated strains (clusters C4–C6) maintained robust growth under oxamate stress, unlike wild strains, positioning oxamate resistance as a practical marker for selecting high-performing, acidifying yeasts for winemaking. Additional inhibitors such as metformin shifted redox metabolism, significantly enhancing glycerol (+25%) and acetic acid (+319%) production. Transcriptomic analyses showed that OXA alone, and even more so the DSF + OXA combination, repressed LDH2 and upregulated GPD1 and oxidative phosphorylation genes, whereas MET caused only moderate changes. This integrated phenomic-transcriptomic approach not only provides valuable tools for yeast screening but also defines a roadmap for optimizing wine composition through the precision selection of L. thermotolerans strains. • LDH inhibition (OXA) lowered lactic acid in L. thermotolerans , raising pH without ethanol loss. • Screening 145 strains at 50% MIC OXA showed oenological clusters more tolerant/efficient than wild. • Under LDH block (OXA ± DSF), GPD1 rose and glycerol increased, consistent with redox-compensation. • Strain-specific rewiring yielded distinct wine endpoints (lactic, acetic, succinic, glycerol). • Targeted inhibition enables scalable tuning of acidity/mouthfeel and selection of robust acidifiers.
No takes yet. Share an insight, caveat, or question.
Jimena-López et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: